ARCHIVES

FDA Approves Votrient For Soft Tissue Sarcomas

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

HPV Can Affect Response To Radiation Therapies

September 28, 2012

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980